Another Headache For Disney: Activist Investor Nelson Peltz Is Back And Said To Be Seeking Board Seats
Activist investor Nelson Peltz, who dropped a long battle with Disney early this year, has amassed a large stake in the media giant and is said to be seeking board seats. Peltz” Trian Fund, one of Disney’s largest investors with a stake valued at upward of $2.5 billion, is expected to request…#activist #nelsonpeltz #disney #peltztrianfund #bobiger #bobchapek #trian #mideast #postcovid #espn (Source: Reuters: Health)
Source: Reuters: Health - October 9, 2023 Category: Consumer Health News Source Type: news
How Old Do You Have to Be To Receive Yellow Fever Vaccine?
Discussion
In the United States, Yellow Fever (YF) is rare and usually due to traveler’s coming to the US from Africa (34 countries) or South America (13 countries, see maps here) This wasn’t always true. There were numerous outbreaks in the past few centuries. However, after the Spanish-American War, a YF commission was sent to Cuba that proved YF was mosquito-borne and 1 year later major improvement was seen due to a multi-pronged mosquito control program.
“In May 1900, the U.S. Army,…formed the U.S. Army Yellow Fever Commission to gather data in Cuba that might inspire improvements in the publi...
Source: PediatricEducation.org - October 9, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Should you pick Novavax ’s COVID-19 shot over mRNA options?
For cardiologist Eric Topol, this week’s vaccine news presented a personal dilemma. Topol, who directs the Scripps Research Translational Institute and is a popular commenter on COVID-19 research, had hoped to get an updated COVID-19 vaccine from Novavax, rather than a messenger RNA (mRNA) shot from Pfizer or Moderna. Novavax relies on an older, protein-based approach that has shown long-lasting effects against other pathogens, and Topol wondered whether it might produce more durable protection. On Tuesday, it seemed he might get his chance: a drugstore he visited for an mRNA vaccine ran out of doses, and hours later the...
Source: ScienceNOW - October 6, 2023 Category: Science Source Type: news
Biden ’s two-headed policy nightmare
If we could pinpoint two major sources of anxiety in the West Wing this week, they’d probably rank like this: 1) Ukraine funding 1b) The southern border, which has managed to become even more of a headache for President Joe Biden as Blue state leaders pile on the pressure. Both particularly messy…#westwing #republicans #dems #hill #andrewbates #ukraine #democrats #richardblumenthal #johnkirby #mikerounds (Source: Reuters: Health)
Source: Reuters: Health - October 5, 2023 Category: Consumer Health News Source Type: news
Why MRIs and Migraine Drugs Are Taking Over Your Social Media Feed
Celebrities, fashion designers and influencers are posting about body scans and Botox competitors at higher volumes. Some are approaching the firms themselves.#botox (Source: Reuters: Health)
Source: Reuters: Health - October 5, 2023 Category: Consumer Health News Source Type: news
COVID-19 Infection, Vaccination Have Little Effect on Migraine Worsening
WEDNESDAY, Oct. 4, 2023 -- COVID-19 infection and vaccination have a negligible effect on migraine worsening, despite patient reports of migraine worsening, according to a study published online Oct. 4 in the European Journal of Neurology.
Laura... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 4, 2023 Category: Pharmaceuticals Source Type: news
COVID Vaccine, Infection May Affect Migraine Course Slightly
(MedPage Today) -- COVID vaccination or SARS-CoV-2 infection may play a small role in migraine worsening, preliminary data suggested.
While some patients reported migraine worsening after either vaccination or infection, headache diaries did not... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - October 4, 2023 Category: Infectious Diseases Source Type: news
Self-Silencing Is Making Women Sick
“Be more disappointing” is not a piece of advice most people would pay money to hear, but in my therapy office, it’s often the most valuable guidance I can give. My clients are mostly women, and nearly all of them struggle with a fear of disappointing others. Our culture rewards women for being perpetually pleasant, self-sacrificing, and emotionally in control, and it can feel counterintuitive for my clients to say “no”—or firmly assert their wants and needs. But my work is about helping them realize that their health might literally depend on it.
[time-brightcove not-tgx=”trueR...
Source: TIME: Health - October 3, 2023 Category: Consumer Health News Authors: Maytal Eyal Tags: Uncategorized freelance Source Type: news
Ruble Sinks Back to 100 Versus Dollar in New Headache for Russia
(Source: Reuters: Health)
Source: Reuters: Health - October 3, 2023 Category: Consumer Health News Source Type: news
Dollar ’s Resurgence Is a Headache for the Rest of the World
The dollar bounced back with a vengeance in the third quarter, threatening global central bankers’ tricky task of bringing down inflation while protecting fragile economic growth. (Source: Reuters: Health)
Source: Reuters: Health - October 2, 2023 Category: Consumer Health News Source Type: news
PayPal Deepens Crypto Footing With Layer-2 Solutions and NFT Patent Applications
Is China even worth the headache its giving Europe? Europe’s foray into international trade with China hasn’t been a walk in the park. As economic dynamics shift and political leaders grapple with decisions that could define the future of their econ... Understanding the Differences Between…#coingecko #blockfolio #cricketworldcup #indiaicc #nearfoundation (Source: Reuters: Health)
Source: Reuters: Health - September 29, 2023 Category: Consumer Health News Source Type: news
Could we end migraines for good? – podcast
British cabinet minister Dehenna Davison recentlyresigned from government, explaining that chronic migraines were making it impossible for her to do her job. Her announcement coincided with a new drug for acute migraines being recommended for use in the NHS. Madeleine Finlay meets Prof Peter Goadsby, whose pioneering research underpins the new drug, to find out about the advances we ’ve made in understanding migraines, and whether we might one day be able to wave goodbye to migraines for goodClips: TalkTV, ITVRead more Guardian reporting on migraine treatmentsContinue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 28, 2023 Category: Science Authors: Presented by Madeleine Finlay, produced by Madeleine Finlay and Joshan Chana, sound design by Tony Onuchukwu, the executive producer is Ellie Bury Tags: Science Health Medical research Women's health Neuroscience Source Type: news
Report: Almost $270 Billion in Leveraged Loans at Default Risk
Leveraged loans were a popular method of financing during the pandemic. Now, with interest rates set to stay high, they’ve turned into a major headache, The Wall Street Journal reported Wednesday (Sept. 27). According to that report — which cites the ratings firm Fitch — close to $270 billion of…#wsj #jamesstaubin #sierramutualfunds #gerardcassidy #rbccapitalmarkets #defaultrisk (Source: Reuters: Health)
Source: Reuters: Health - September 27, 2023 Category: Consumer Health News Source Type: news
Recent Studies in Parkinson's, Headache, Stroke, and Obesity Recent Studies in Parkinson's, Headache, Stroke, and Obesity
Hans-Christoph Diener, MD, PhD, discusses recent studies in neurology and internal medicine.Medscape Neurology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 27, 2023 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news
